EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced that it has entered into a definitive agreement to sell all manufacturing and supply rights for its SmartDose® 3.5mL On-Body ...
West Pharmaceutical Services, Inc. WST delivered adjusted fourth-quarter 2025 earnings per share (EPS) of $2.04, which moved up 12.1% year over year. The figure topped the Zacks Consensus Estimate by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results